174 related articles for article (PubMed ID: 21658330)
1. Platelet amyloid precursor protein isoform expression in Alzheimer's disease: evidence for peripheral marker.
Vignini A; Sartini D; Morganti S; Nanetti L; Luzzi S; Provinciali L; Mazzanti L; Emanuelli M
Int J Immunopathol Pharmacol; 2011; 24(2):529-34. PubMed ID: 21658330
[TBL] [Abstract][Full Text] [Related]
2. Amyloid precursor protein expression is enhanced in human platelets from subjects with Alzheimer's disease and frontotemporal lobar degeneration: a real-time PCR study.
Vignini A; Morganti S; Salvolini E; Sartini D; Luzzi S; Fiorini R; Provinciali L; Di Primio R; Mazzanti L; Emanuelli M
Exp Gerontol; 2013 Dec; 48(12):1505-8. PubMed ID: 24400342
[TBL] [Abstract][Full Text] [Related]
3. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
4. Amyloid precursor protein gene isoforms in Alzheimer's disease and other neurodegenerative disorders.
Panegyres PK; Zafiris-Toufexis K; Kakulas BA
J Neurol Sci; 2000 Feb; 173(2):81-92. PubMed ID: 10675649
[TBL] [Abstract][Full Text] [Related]
5. Amyloid precursor protein mRNA levels in Alzheimer's disease brain.
Preece P; Virley DJ; Costandi M; Coombes R; Moss SJ; Mudge AW; Jazin E; Cairns NJ
Brain Res Mol Brain Res; 2004 Mar; 122(1):1-9. PubMed ID: 14992810
[TBL] [Abstract][Full Text] [Related]
6. Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease.
Plagg B; Marksteiner J; Kniewallner KM; Humpel C
Biogerontology; 2015 Aug; 16(4):543-58. PubMed ID: 25947203
[TBL] [Abstract][Full Text] [Related]
7. Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease.
Di Luca M; Pastorino L; Bianchetti A; Perez J; Vignolo LA; Lenzi GL; Trabucchi M; Cattabeni F; Padovani A
Arch Neurol; 1998 Sep; 55(9):1195-200. PubMed ID: 9740113
[TBL] [Abstract][Full Text] [Related]
8. The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives.
Palmert MR; Podlisny MB; Golde TE; Cohen ML; Kovacs DM; Tanzi RE; Gusella JF; Whitehouse PJ; Witker DS; Oltersdorf T
Prog Clin Biol Res; 1989; 317():971-84. PubMed ID: 2513588
[TBL] [Abstract][Full Text] [Related]
9. APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis.
Zhan SS; Sandbrink R; Beyreuther K; Schmitt HP
Clin Neuropathol; 1995; 14(3):142-9. PubMed ID: 7671455
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
Liu CG; Wang JL; Li L; Wang PC
Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
[TBL] [Abstract][Full Text] [Related]
11. Detection of distinct isoform patterns of the beta-amyloid precursor protein in human platelets and lymphocytes.
Schlossmacher MG; Ostaszewski BL; Hecker LI; Celi A; Haass C; Chin D; Lieberburg I; Furie BC; Furie B; Selkoe DJ
Neurobiol Aging; 1992; 13(3):421-34. PubMed ID: 1625772
[TBL] [Abstract][Full Text] [Related]
12. APP gene family: unique age-associated changes in splicing of Alzheimer's betaA4-amyloid protein precursor.
Sandbrink R; Masters CL; Beyreuther K
Neurobiol Dis; 1994 Nov; 1(1-2):13-24. PubMed ID: 9216982
[TBL] [Abstract][Full Text] [Related]
13. The platelet amyloid precursor protein ratio as a diagnostic marker for Alzheimer's disease in Thai patients.
Srisawat C; Junnu S; Peerapittayamongkol C; Futrakul A; Soi-ampornkul R; Senanarong V; Praditsuwan R; Assantachai P; Neungton N
J Clin Neurosci; 2013 May; 20(5):644-8. PubMed ID: 23453155
[TBL] [Abstract][Full Text] [Related]
14. Age-related changes in the proportion of amyloid precursor protein mRNAs in Alzheimer's disease and other neurological disorders.
Tanaka S; Liu L; Kimura J; Shiojiri S; Takahashi Y; Kitaguchi N; Nakamura S; Ueda K
Brain Res Mol Brain Res; 1992 Oct; 15(3-4):303-10. PubMed ID: 1331685
[TBL] [Abstract][Full Text] [Related]
15. Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain.
Moir RD; Lynch T; Bush AI; Whyte S; Henry A; Portbury S; Multhaup G; Small DH; Tanzi RE; Beyreuther K; Masters CL
J Biol Chem; 1998 Feb; 273(9):5013-9. PubMed ID: 9478949
[TBL] [Abstract][Full Text] [Related]
16. The effects of Alzheimer's disease, other dementias, and premortem course on beta-amyloid precursor protein messenger RNA in frontal cortex.
Harrison PJ; Barton AJ; Procter AW; Bowen DM; Pearson RC
J Neurochem; 1994 Feb; 62(2):635-44. PubMed ID: 8294927
[TBL] [Abstract][Full Text] [Related]
17. Quantification of APP and APLP2 mRNA in APOE genotyped Alzheimer's disease brains.
Johnston JA; Norgren S; Ravid R; Wasco W; Winblad B; Lannfelt L; Cowburn RF
Brain Res Mol Brain Res; 1996 Dec; 43(1-2):85-95. PubMed ID: 9037522
[TBL] [Abstract][Full Text] [Related]
18. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.
Tang K; Hynan LS; Baskin F; Rosenberg RN
J Neurol Sci; 2006 Jan; 240(1-2):53-8. PubMed ID: 16256140
[TBL] [Abstract][Full Text] [Related]
19. Enhanced production of amyloid precursor protein mRNA by peripheral mononuclear blood cell in Alzheimer's disease.
Jiang S; Zhang M; Ren D; Tang G; Lin S; Qian Y; Zhang Y; Jiang K; Li F; Wang D
Am J Med Genet B Neuropsychiatr Genet; 2003 Apr; 118B(1):99-102. PubMed ID: 12627474
[TBL] [Abstract][Full Text] [Related]
20. APP processing and the APP-KPI domain involvement in the amyloid cascade.
Menéndez-González M; Pérez-Pinera P; Martínez-Rivera M; Calatayud MT; Blázquez Menes B
Neurodegener Dis; 2005; 2(6):277-83. PubMed ID: 16909010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
